课题基金 / 基金详情

The mechanism of liver injury by hepatitis B virus, using a novel adenovirus expressing HBV

The mechanism of liver injury by hepatitis B virus, using a novel adenovirus expressing HBV
乙型肝炎病毒肝损伤机制,使用表达乙型肝炎病毒的新型腺病毒
批准号:
15590639
负责人:
MURATA Kazumoto
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

MURATA Kazumoto的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Five days after intravenous injection of adenovirus expressing HBV (adeno-HBV) to BALB/c mice, serum HBsAg showed a peak whereas no elevation in adeno-GFP (control virus) injected mice during follow-up. The number of intrahepatic lymphocytes increased 1 day after injection in mice injected either adeno-HBV or adeno-GFP, suggesting that this effect is due to adenovirus itself. Howevr, 5 days after injection, the number of NK cells increased again whereas no increase in adeno-GFP injected mice. The number of CD1d tertramer positive cells decreased 1 day after injection by both adenovirus. The number of CD1d tetramer positive cells recovered in a few days in adeno-GFP injected mice. In contrast, it was not recovered until 10 days after injection of adeno-HBV. NK cytotoxicity using Yac-1 cells was up-regulated 1 day after injection of both virus. Then, it gradually went back to normal in adeno-GFP injected mice whereas iNK cytotoxicity up-regulated again in adeno-HBV injected mice. From the differences on Day 5 after injection, HBV may decrease the number of CD1d tetramer positive cells and increase the number of NK cells. Injection of adeno-HBV to GD1 knockout mice demonstrated the disappearance of NK cytotoxicity. These results may indicate that HBV up-regulated NK cells through NKT cells activation.
期刊论文(30)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间: 2003
期刊: Hepato-Gastroenterology 50
影响因子: --
作者: [Yamamoto N, Murata K., Qio M, Murata K, Murata K, Murata K]
通讯作者: Murata K
DOI: 10.1073/pnas.1131929100
发表时间: 2003-05-27
期刊: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
影响因子: 11.1
作者: [Murata, K, Lechmann, M, Liang, TJ]
通讯作者: Liang, TJ
Low-dose chemotherapy of cisplatin and 5-fluorouracil or doxorubicin via implanted infusion port for unresectable HCC
通过植入输注端口进行顺铂和 5-氟尿嘧啶或多柔比星低剂量化疗治疗不可切除的 HCC
DOI: --
发表时间: 2003
期刊: Anticancer Research 23
影响因子: --
作者: [Yamamoto N, Murata K., Qio M, Murata K]
通讯作者: Murata K
Low-dose chemotherapy of cisplatin and 5-fluorouracil or doxorubic in via implanted infusion port for unresectable HCC
通过植入输注端口进行顺铂和 5-氟尿嘧啶或多柔比的低剂量化疗治疗不可切除的 HCC
DOI: --
发表时间: 2003
期刊: Anticancer Research 23
影响因子: --
作者: [Murata K, Shiraki K, Kawakita T, Yamamoto N, Okano H, et al., Murata K]
通讯作者: Murata K
8
    Comprehensive analyses for the mechanism of PIVKA-II production from hepatocellular carcinoma
    The mechanism of chronicity of hepatitis B (inhibition of antigen presentation by HBX protein)
    海外基金